Biospecimen Collection + Nasal Swab + Survey Administration + REMDESIVIR for respiratory syncytial virus infections

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 10 Feb 2025: Trial registered, NCT06817889
  2. 23 Dec 2025: Trial started, NCT06817889

The trials

NCT06817889: Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals

State
Under way
Phase
Phase 2
People
60 planned
Started
23 Dec 2025
Primary completion
30 Nov 2027
Arms
Treatment (remdesivir)
Results
None posted
  1. 10 Feb 2025: Trial registered
  2. 23 Dec 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.